Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Randomized, Placebo-Controlled, Double Blind Study of the Atorvastatin: Effect on Patients With Chronic Subdural Hematoma

NCT02024373 is registered in ClinicalTrials.gov with Oriental Neurosurgery Evidence-Based-Study Team as lead sponsor.

NCT NCT02024373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02024373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Randomized, Placebo-Controlled, Double Blind Study of the Atorvastatin: Effect on Patients With Chronic Subdural Hematoma
Lead sponsor
Oriental Neurosurgery Evidence-Based-Study Team
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2013
Completion date
September 30, 2016
Enrollment
200 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

chronic subdural hematoma